bioRxivCancer Biology
Multimodal CustOmics: A Unified and Interpretable Multi-Task Deep Learning Framework for Multimodal Integrative Data Analysis in Oncology
H. Benkirane, M. Vakalopoulou, D. Planchard, J. Adam, K. Olaussen, S. Michiels, P.-H. Cournede
Abstract
Characterizing cancer poses a delicate challenge as it involves deciphering complex biological interactions within the tumors microenvironment. Histology images and molecular profiling of tumors are often available in clinical trials and can be leveraged to understand these interactions. However, despite recent advances in representing multimodal data for weakly supervised tasks in the medical domain, numerous challenges persist in achieving a coherent and interpretable fusion of whole slide images and multi-omics data. Each modality operates at distinct biological levels, introducing substantial correlations both between and within data sources. In response to these challenges, we propose a deep-learning-based approach designed to represent multimodal data for precision medicine in a readily interpretable manner. While demonstrating superior performance compared to state-of-the-art methods across multiple test cases, our approach also provides robust results and extracts various scores characterizing the activity of each modality and their interactions at the pathway and gene levels. The strength of our method lies in its capacity to unravel pathway activation through multimodal relationships and extend enrichment analysis to spatial data for supervised tasks. We showcase the efficiency and robustness of its predictive capacity and interpretation scores through an extensive exploration of multiple TCGA datasets and validation cohorts, underscoring its value in advancing our understanding of cancer. The method is publicly available in Github.
- organism: human
- assay: bulk RNA-seq
- assay: spatial transcriptomics
- assay: imaging
- research focus: gene regulatory network inference
- research focus: cell-cell communication
- research focus: drug response / drug discovery
- approach: deep learning
- approach: contrastive learning
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Development of Biologically Interpretable Multimodal Deep Learning Model for Cancer Prognosis Prediction
Z. L. Azher, L. J. Vaickus, … J. Levy·bioRxiv·Oct 30, 2021
- Assessment of Emerging Pretraining Strategies in Interpretable Multimodal Deep Learning for Cancer Prognostication
Z. Azher, A. Suvarna, … J. Levy·bioRxiv·Nov 21, 2022
- Deep Learning with Multimodal Representation for Pancancer Prognosis Prediction
Anika Cheerla, Olivier Gevaert·BioinformaticsPeer-reviewed·May 9, 2019
- Pathformer: a biological pathway informed Transformer integrating multi-omics data for disease diagnosis and prognosis
Xiaofan Liu, Yuhuan Tao, … Zhi John Lu·bioRxiv·May 23, 2023
- Multi-omics integration and batch correction using a modality-agnostic deep learning framework
Jose Ignacio Alvira Larizgoitia, Gabriele Partel, … Alejandro Sifrim·bioRxiv·Oct 21, 2025
- Integrating Multi-Modal Cancer Data Using Deep Latent Variable Path Modelling
A. J. Ing, Álvaro Andrades, … Jan O. Korbel·Nature Machine IntelligencePeer-reviewed·Jul 22, 2025